scholarly journals Neck Irradiation: a Risk Factor for Occlusive Carotid Artery Disease

2002 ◽  
Vol 23 (4) ◽  
pp. 299-302 ◽  
Author(s):  
M. Halak ◽  
S. Fajer ◽  
H. Ben-Meir ◽  
Z. Loberman ◽  
B. Weller ◽  
...  
Keyword(s):  
Risk Factor ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Neck Irradiation ◽  
Artery Disease

Snoring and carotid artery disease: A new risk factor emerges

2018 ◽  
Vol 129 (1) ◽  
pp. 265-268 ◽  
Author(s):  
Robert Deeb ◽  
Matthew R. Smeds ◽  
Jonathan Bath ◽  
Edward Peterson ◽  
Matthew Roberts ◽  
...  
Keyword(s):  
Risk Factor ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Artery Disease

scholarly journals Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation

2009 ◽  
Vol 53 (4) ◽  
pp. 615-621 ◽  
Author(s):  
Kathleen A. Meeske ◽  
Stuart E. Siegel ◽  
Vicente Gilsanz ◽  
Leslie Bernstein ◽  
Mary B. Nelson ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Cancer Survivors ◽  
Pediatric Cancer ◽  
Carotid Artery Disease ◽  
Pediatric Cancer Survivors ◽  
Neck Irradiation ◽  
Artery Disease

COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD)

2020 ◽  
Author(s):  
Daniela Buklioska Ilievska ◽  
Jordan Minov ◽  
Nade Kochovska Kamchevska ◽  
Marjan Baloski ◽  
Bozidar Poposki
Keyword(s):  
Risk Factor ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Artery Disease

scholarly journals Prevalence of carotid artery disease in patients with metabolic syndrome

2020 ◽  
Vol 12 ◽  
Author(s):  
Tatjana Deleva-Stoshevska
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Carotid Artery ◽  
Carotid Artery Disease ◽  
Significant Risk ◽  
Adequate Treatment ◽  
Effective Prevention ◽  
Linear Probe ◽  
Artery Disease ◽  
The Impact

There is a growing body of scientific evidence on the impact of metabolic syndrome (MetS) on the progression of atherosclerosis, imposing the need for research of the association of MetS with carotid artery disease (CAD) as a significant risk factor for cerebrovascular insult (CVI) and transient ischemic attack (TIA). The aim of the study was to determine the prevalence of CAD as a risk factor for CVI and TIA in subjects with MetS. Material and methods: A cross-sectional study was performed including a total of 118 subjects, 65 men, 53 women, with MetS according to NCEP ATP III criteria that were analyzed clinically, biochemically and ultrasonographically in the City General Hospital "8th September" - Skopje in the period from January 2017 to January 2018. Waist circumference, blood pressure, glycemia, triglycerides, and HDL cholesterol were determined according to standard routine protocols. The evaluation of the extracranial carotid trunk was done with a Color Doppler Duplex sonography with a linear probe of 7.5MHz. CAD assessment was performed using Ultrasound Consensus Criteria for Carotid Stenosis. An objective neurological assessment of the existence of CVI and TIA was performed by a standard protocol for neurological examination and brain CT results from medical history were reviewed. Results: The prevalence of CAD in this study was 77 subjects (65.25%), of which 35 subjects (29.66%) had symptomatic CAD, 17 subjects (48.57%) had CVI, 18 subjects (51.43%) had TIA. Regarding the degree of carotid artery stenosis (CAS) in the total number of subjects with MetS and CAD, no subjects with normal findings were registered, 16 subjects had stenosis <50% , 29 subjects had stenosis 50-69% , 23 subjects had stenosis 70-99% , while 9 subjects had occlusion. Conclusion: The results obtained in this study have shown that asymptomatic CAD is dominant in patients with MetS, which further imposed the need for timely extracranial ultrasonographic evaluation of the carotid trunk. This would achieve both effective prevention and adequate treatment of CVI and TIA, thereby reducing morbidity and mortality from cerebrovascular events which has a great health and socioeconomic significance.

scholarly journals RR19. Carotid Artery Disease: Risk Factor Analysis in a Cohort of 3.9 Million Individuals

2010 ◽  
Vol 51 (6) ◽  
pp. 95S-96S
Author(s):  
Giampaolo Greco ◽  
Natalia N. Egorova ◽  
K. Craig Kent ◽  
Robert M. Zwolak ◽  
Andrew Manganaro ◽  
...  
Keyword(s):  
Factor Analysis ◽  
Risk Factor ◽  
Carotid Artery ◽  
Disease Risk ◽  
Carotid Artery Disease ◽  
Risk Factor Analysis ◽  
Disease Risk Factor ◽  
Artery Disease

Carotid artery disease in older people: clinical features and management

2010 ◽  
Vol 21 (2) ◽  
pp. 141-151
Author(s):  
A Ross Naylor
Keyword(s):  
Risk Factor ◽  
Carotid Artery ◽  
Elderly Patients ◽  
Medical Therapy ◽  
Carotid Artery Disease ◽  
Minor Stroke ◽  
Carotid Disease ◽  
Risk Factor Control ◽  
Artery Disease ◽  
Best Medical Therapy

SummaryThe ‘take home’ messages for managing elderly patients with symptomatic carotid disease are that they need to be investigated as soon as possible after onset of the index event and that someone has to take active responsibility for ensuring that risk factor control and best medical therapy is started as soon as possible. In this modern era, patients suffering a transient ischaemic attack/minor stroke should be seen in dedicated, rapidly accessible single visit clinics, and those found to have significant carotid disease should generally be admitted and undergo expedited carotid endarterectomy (CEA) unless contra-indicated. Every centre should now aim to be performing carotid surgery within 14 days of onset of symptoms, with this threshold likely to become even shorter in the future. The current culture of allowing delays to treatment should be considered unacceptable. Evidence suggests that the risk of procedural stroke is lower in higher volume centres and this should be considered when planning referrals. Recently symptomatic elderly patients deemed unfit for CEA should be considered for carotid artery stenting (CAS), but with the caveat that this may be associated with an increased risk of procedural stroke. In this situation, every patient should be considered on an individual basis and no symptomatic patient should be denied access to surgery simply on the grounds of age. Meta-analyses of data from the international trials have clearly shown that patients aged >75 years gain considerably more benefit from CEA than any other age group. In contrast, there is no compelling evidence that patients aged >75 years with asymptomatic carotid artery disease benefit from CEA or CAS. For this category of patients, risk factor control and best medical therapy should remain the first line of management.

Sign in / Sign up

Export Citation Format

Share Document